Revance Therapeutics (NASDAQ:RVNC) Shares Gap Up Following Better-Than-Expected Earnings

Shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) gapped up before the market opened on Thursday following a better than expected earnings announcement. The stock had previously closed at $5.66, but opened at $6.15. Revance Therapeutics shares last traded at $6.87, with a volume of 1,342,623 shares trading hands. The biopharmaceutical company reported […]

Leave a Reply

Your email address will not be published.

Previous post ‘Outlaw Posse’ takes familiar road to Old West
Next post Osino Resources Corp. (OTCMKTS:OSIIF) Short Interest Down 99.2% in February